Literature DB >> 27020813

Epigallocatechin gallate attenuates cardiopulmonary bypass-associated lung injury.

Bernhard Kasper1, Aida Salameh2, Miriam Krausch3, Philipp Kiefer3, Martin Kostelka3, Friedrich Wilhelm Mohr3, Stefan Dhein3.   

Abstract

BACKGROUND: Lung dysfunction constitutes a severe complication after major cardiac surgery with cardiopulmonary bypass (CPB), substantially contributing to postoperative morbidity and mortality. The current possibilities of preventive and therapeutic interventions, however, remain insufficient. We, therefore, investigated the effects of intraoperative application of the antioxidant and anti-inflammatory green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) on CPB-associated lung injury.
MATERIALS AND METHODS: Thirty piglets (8-15 kg) were divided into four groups: sham-operated and saline-treated control group (n = 7); sham-operated and EGCG-treated control group (EGCG-control group; n = 7); CPB group (n = 10); and CPB + EGCG group (n = 6). The CPB groups underwent 120 min of CPB followed by 90 min of recovery time. In the CPB + EGCG group, EGCG (10 mg/kg body weight) was administered intravenously before and after CPB. Hemodynamic monitoring, blood gas analysis, hematoxylin-eosin staining, and immunohistochemistry of lung tissue were performed.
RESULTS: Histologic examination revealed thickening of the alveolar wall and enhanced alveolar neutrophil infiltration in the CPB group (P < 0.05) compared with those in the control group, which was prevented by EGCG (P < 0.05). In the CPB group, higher formation of poly(ADP-ribose) and nuclear translocation of apoptosis-inducing factor was detected in comparison with those in the control group (P < 0.001), which were both reduced in the CPB + EGCG group (P < 0.001). Compared with the control group, the EGCG-control group showed thickening of the alveolar wall and increased neutrophil infiltration (P < 0.05).
CONCLUSIONS: CPB leads to lung edema, pulmonary neutrophil infiltration, and presumably initiation of poly(ADP-ribose) polymerase-dependent cell death signaling in the lung. EGCG appears to attenuate CPB-associated lung injury, suggesting that this may provide a novel pharmacologic approach.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis-inducing factor; Cardiopulmonary bypass; Epigallocatechin gallate; Lung injury; Poly(ADP-ribose) polymerase

Mesh:

Substances:

Year:  2015        PMID: 27020813     DOI: 10.1016/j.jss.2015.11.007

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

Review 1.  Perspectives on the recent developments with green tea polyphenols in drug discovery.

Authors:  Feng Li; Yongli Wang; Dapeng Li; Yilun Chen; Xuguang Qiao; Rania Fardous; Ashton Lewandowski; Jinbao Liu; Tak-Hang Chan; Q Ping Dou
Journal:  Expert Opin Drug Discov       Date:  2018-04-24       Impact factor: 6.098

Review 2.  Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass.

Authors:  Aida Salameh; Stefan Dhein; Ingo Dähnert; Norbert Klein
Journal:  Int J Mol Sci       Date:  2016-11-21       Impact factor: 5.923

3.  Epigallocatechin Gallate Attenuates Hip Fracture-Induced Acute Lung Injury by Limiting Mitochondrial DNA (mtDNA) Release.

Authors:  Xiao-Dan Zhao; Hao Liu; Tao Li; Quan Gong; Wen-Li Zhang
Journal:  Med Sci Monit       Date:  2017-07-12

4.  XueFu ZhuYu Decoction Alleviates Cardiopulmonary Bypass-Induced NLRP3 Inflammasome-Dependent Pyroptosis by Inhibiting IkB-α/NF-κB Pathway in Acute Lung Injury Rats.

Authors:  Hui Li; Wenlei Zhang; Qiaoqin Lou; Yuejin Chang; Zhenhao Lin; Lingli Lou
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-10       Impact factor: 2.650

5.  Epigallocatechin Gallate Reduces Ischemia/Reperfusion Injury in Isolated Perfused Rabbit Hearts.

Authors:  Aida Salameh; Roxana Schuster; Ingo Dähnert; Johannes Seeger; Stefan Dhein
Journal:  Int J Mol Sci       Date:  2018-02-23       Impact factor: 5.923

6.  Anti-oxidative or anti-inflammatory additives reduce ischemia/reperfusions injury in an animal model of cardiopulmonary bypass.

Authors:  Aida Salameh; Stefan Dhein; Marie Mewes; Sophie Sigusch; Philipp Kiefer; Marcel Vollroth; Johannes Seeger; Ingo Dähnert
Journal:  Saudi J Biol Sci       Date:  2019-04-05       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.